Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -205,192 | -153,638 | -79,577 | -46,151 | -142,309 |
| Depreciation Amortization | 1,023 | 738 | 470 | 195 | 302 |
| Accounts receivable | -5,382 | -2,964 | -2,041 | -1,847 | -1,067 |
| Accounts payable and accrued liabilities | -4 | -3,252 | -2,821 | -4,647 | 4,126 |
| Other Working Capital | 10,578 | -3,974 | -8,940 | 6,410 | -15,227 |
| Other Operating Activity | 52,310 | 37,688 | 4,874 | 11,582 | 49,346 |
| Operating Cash Flow | $-146,667 | $-125,402 | $-88,035 | $-34,458 | $-104,829 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 8,233 |
| PPE Investments | -2,939 | -2,886 | -2,289 | -956 | -2,254 |
| Net Acquisitions | 250 | 250 | 250 | 250 | 250 |
| Investing Cash Flow | $-2,689 | $-2,636 | $-2,039 | $-706 | $6,229 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 50,000 |
| Common Stock Issued | 81,990 | 81,889 | 81,778 | 28,050 | 107,968 |
| Other Financing Activity | 8,703 | -1,062 | -967 | -44 | -3,742 |
| Financing Cash Flow | $90,693 | $80,827 | $80,811 | $28,006 | $154,226 |
| Beginning Cash Position | 72,251 | 72,251 | 72,251 | 72,251 | 16,625 |
| End Cash Position | 13,588 | 25,040 | 62,988 | 65,093 | 72,251 |
| Net Cash Flow | $-58,663 | $-47,211 | $-9,263 | $-7,158 | $55,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -146,667 | -125,402 | -88,035 | -34,458 | -104,829 |
| Capital Expenditure | -2,939 | -2,886 | -2,289 | -956 | -2,254 |
| Free Cash Flow | -149,606 | -128,288 | -90,324 | -35,414 | -107,083 |